0001685428-19-000004.txt : 20190904
0001685428-19-000004.hdr.sgml : 20190904
20190903173514
ACCESSION NUMBER: 0001685428-19-000004
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190904
DATE AS OF CHANGE: 20190903
EFFECTIVENESS DATE: 20190904
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: LumiraDx Ltd
CENTRAL INDEX KEY: 0001685428
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-347906
FILM NUMBER: 191072865
BUSINESS ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2AQ
BUSINESS PHONE: 011 44 1786 430411
MAIL ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2AQ
D
1
primary_doc.xml
X0708
D
LIVE
0001685428
LumiraDx Ltd
3 MORE LONDON RIVERSIDE
LONDON
X0
UNITED KINGDOM
SE1 2AQ
011 44 1786 430411
CAYMAN ISLANDS
None
None
Other
Exempted company limited by shares
true
2016
Ron
Zwanziger
c/o LumiraDx Limited
3 More London Riverside
London
X0
UNITED KINGDOM
SE 1 2AQ
Executive Officer
Director
David
Scott
c/o LumiraDx Limited
3 More London Riverside
London
X0
UNITED KINGDOM
SE 1 2AQ
Executive Officer
Director
Jerry
McAleer
c/o LumiraDx Limited
3 More London Riverside
London
X0
UNITED KINGDOM
SE 1 2AQ
Executive Officer
Director
David
Walton
c/o LumiraDx Limited
3 More London Riverside
London
X0
UNITED KINGDOM
SE 1 2AQ
Executive Officer
Nigel
Lindner
c/o LumiraDx Limited
3 More London Riverside
London
X0
UNITED KINGDOM
SE1 2AQ
Executive Officer
Peter
Welch
c/o LumiraDx Limited
3 More London Riverside
London
X0
UNITED KINGDOM
SE 1 2AQ
Executive Officer
Veronique
Ameye
c/o LumiraDx Limited
3 More London Riverside
London
X0
UNITED KINGDOM
SE 1 2AQ
Executive Officer
Tom
Quinlan
c/o LumiraDx Limited
3 More London Riverside
London
X0
UNITED KINGDOM
SE 1 2AQ
Executive Officer
Peter
Scheu
c/o LumiraDx Limited
3 More London Riverside
London
X0
UNITED KINGDOM
SE 1 2AQ
Executive Officer
Dorian
LeBlanc
c/o LumiraDx Limited
3 More London Riverside
London
X0
UNITED KINGDOM
SE 1 2AQ
Executive Officer
Donald
Berwick
c/o LumiraDx Limited
3 More London Riverside
London
X0
UNITED KINGDOM
SE 1 2AQ
Director
Bruce
Keogh
c/o LumiraDx Limited
3 More London Riverside
London
X0
UNITED KINGDOM
SE 1 2AQ
Director
Lurene
Joseph
c/o LumiraDx Limited
3 More London Riverside
London
X0
UNITED KINGDOM
SE 1 2AQ
Director
Lu
Huang
c/o LumiraDx Limited
3 More London Riverside
London
X0
UNITED KINGDOM
SE 1 2AQ
Director
Troyen
Brennan
c/o LumiraDx Limited
3 More London Riverside
London
X0
UNITED KINGDOM
SE 1 2AQ
Director
Suresh
Vazirani
c/o LumiraDx Limited
3 More London Riverside
London
X0
UNITED KINGDOM
SE 1 2AQ
Director
Other Health Care
Decline to Disclose
- 06b
false
2017-11-28
false
true
true
false
0
U.S. Boston Capital Corporation
5251
None
None
55 Old Bedford Road
Lincoln
MA
MASSACHUSETTS
01773
CA
CALIFORNIA
CT
CONNECTICUT
DC
DISTRICT OF COLUMBIA
FL
FLORIDA
GA
GEORGIA
HI
HAWAII
IL
ILLINOIS
ME
MAINE
MD
MARYLAND
MA
MASSACHUSETTS
MI
MICHIGAN
MN
MINNESOTA
NH
NEW HAMPSHIRE
NY
NEW YORK
NC
NORTH CAROLINA
OH
OHIO
PA
PENNSYLVANIA
SC
SOUTH CAROLINA
TX
TEXAS
UT
UTAH
VT
VERMONT
WY
WYOMING
false
76675000
76675000
0
Amount sold shown in item 13 and number of investors shown in item 14 include $8,800,000 from 15 non-US investors.
false
188
1541226
true
0
0
false
LumiraDx Ltd
/s/Dorian LeBlanc
Dorian LeBlanc
CFO
2019-09-03